13-Feb-2025 4:46 PM CST - MSN Boston Scientific EVP sells shares worth $671,249 John Bradley Sorenson, Executive Vice President of Global Operations at Boston Scientific Corp (NYSE:BSX), recently made significant transactions involving the company's stock. On February 12, Sorenson sold 6,
13-Feb-2025 4:35 PM CST - Investing Boston Scientific's Jeffrey Mirviss sells $1.37 million in stock Jeffrey B. Mirviss, Executive Vice President and President of Peripheral Interventions at Boston Scientific Corp (NYSE:BSX), recently reported a significant stock transaction. According to an SEC filing,
13-Feb-2025 8:01 AM CST - Benzinga Sell Alert: EDWARD LUDWIG Cashes Out $1.27M In Boston Scientific Stock What Happened: After conducting a thorough analysis, LUDWIG sold 12,000 shares of Boston Scientific. This information was disclosed in a Form 4 filing with the U.S. Securities and Exchange Commission on Thursday. The total transaction value is $1,265,815.
12-Feb-2025 10:39 AM CST - Zacks EMEA Expansion to Support BSX Stock Amid Fierce Competition Boston Scientific BSX is gaining from new product launches and accretive acquisitions. Yet, unfavorable currency movement and macroeconomic concerns are major dampeners. The stock carries a Zacks Rank #3 (Hold).
10-Feb-2025 5:00 PM CST - MSN Boston Scientific EVP sells $685,244 in stock John Bradley Sorenson, Executive Vice President of Global Operations at Boston Scientific Corp (NYSE:BSX), recently sold a significant portion of company stock. According to a filing with the Securities and Exchange Commission,
10-Feb-2025 8:24 AM CST - Investing Stifel raises Boston Scientific stock target to $120, keeps buy rating Stifel analysts increased their price target on Boston Scientific Corporation (NYSE:BSX) shares from $115.00 to $120.00, while reiterating a Buy rating for the medical device company. The adjustment follows recent meetings that left analysts with a positive outlook on the company's future financial performance.
10-Feb-2025 1:36 AM CST - Business Insider Barclays Reaffirms Their Buy Rating on Boston Scientific (BSX) In a report released today, Matt Miksic from Barclays maintained a Buy rating on Boston Scientific (BSX - Research Report), with a price target
13-Feb-2025 4:46 PM CST - MSN Boston Scientific EVP sells shares worth $671,249 John Bradley Sorenson, Executive Vice President of Global Operations at Boston Scientific Corp (NYSE:BSX), recently made significant transactions involving the company's stock. On February 12, Sorenson sold 6,
13-Feb-2025 4:35 PM CST - Investing Boston Scientific's Jeffrey Mirviss sells $1.37 million in stock Jeffrey B. Mirviss, Executive Vice President and President of Peripheral Interventions at Boston Scientific Corp (NYSE:BSX), recently reported a significant stock transaction. According to an SEC filing,
13-Feb-2025 8:01 AM CST - Benzinga Sell Alert: EDWARD LUDWIG Cashes Out $1.27M In Boston Scientific Stock What Happened: After conducting a thorough analysis, LUDWIG sold 12,000 shares of Boston Scientific. This information was disclosed in a Form 4 filing with the U.S. Securities and Exchange Commission on Thursday. The total transaction value is $1,265,815.
12-Feb-2025 10:39 AM CST - Zacks EMEA Expansion to Support BSX Stock Amid Fierce Competition Boston Scientific BSX is gaining from new product launches and accretive acquisitions. Yet, unfavorable currency movement and macroeconomic concerns are major dampeners. The stock carries a Zacks Rank #3 (Hold).
10-Feb-2025 5:00 PM CST - MSN Boston Scientific EVP sells $685,244 in stock John Bradley Sorenson, Executive Vice President of Global Operations at Boston Scientific Corp (NYSE:BSX), recently sold a significant portion of company stock. According to a filing with the Securities and Exchange Commission,
10-Feb-2025 8:24 AM CST - Investing Stifel raises Boston Scientific stock target to $120, keeps buy rating Stifel analysts increased their price target on Boston Scientific Corporation (NYSE:BSX) shares from $115.00 to $120.00, while reiterating a Buy rating for the medical device company. The adjustment follows recent meetings that left analysts with a positive outlook on the company's future financial performance.
10-Feb-2025 1:36 AM CST - Business Insider Barclays Reaffirms Their Buy Rating on Boston Scientific (BSX) In a report released today, Matt Miksic from Barclays maintained a Buy rating on Boston Scientific (BSX - Research Report), with a price target